New chemo combo shows promise in Triple-Negative breast cancer

NCT ID NCT03301350

Completed Disease control Sponsor: University of Wisconsin, Madison Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a specific chemotherapy combination given before surgery for people with triple-negative breast cancer. The goal was to see if the treatment could completely eliminate the cancer from the breast and lymph nodes. 29 participants received the drugs, and the main outcome measured was the rate of complete cancer disappearance. This approach aims to control the disease and improve surgical outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER TRIPLE NEGATIVE BREAST CANCER

Contacts and locations

Locations

Aspirus Regional Cancer Center Wausau

Wausau, Wisconsin, 54401, United States
Columbia St. Mary's Cancer Center

Milwaukee, Wisconsin, 53211, United States
Medical College of Wisconsin

Milwaukee, Wisconsin, 53226, United States
ProHealth Care

Waukesha, Wisconsin, 53188, United States
Swedish American Hospital

Rockford, Illinois, 61104, United States
University of Wisconsin Carbone Cancer Center

Madison, Wisconsin, 53792, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.